Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 3,138 | 3,053 | 3,805 | 2,043 | 1,666 |
| Gross Profit | 3,138 | 3,053 | 3,805 | 2,043 | 1,666 |
| Operating Expenses | 13,679 | 14,894 | 12,809 | 12,619 | 11,105 |
| Operating Income | -10,541 | -11,841 | -9,004 | -10,576 | -9,439 |
| Other Income | 25 | 150 | 398 | 408 | 416 |
| Pre-tax Income | -10,516 | -11,691 | -8,606 | -10,168 | -9,023 |
| Net Income Continuous | -10,516 | -11,691 | -8,606 | -10,168 | -9,023 |
| Net Income | $-10,516 | $-11,691 | $-8,606 | $-10,168 | $-9,023 |
| EPS Basic Total Ops | -1.36 | -1.56 | -0.32 | -1.36 | -1.24 |
| EPS Basic Continuous Ops | -1.38 | -1.55 | -0.31 | -1.36 | -1.24 |
| EPS Diluted Total Ops | -1.36 | -1.56 | -0.32 | -1.36 | -1.24 |
| EPS Diluted Continuous Ops | -1.38 | -1.55 | -0.31 | -1.36 | -1.24 |
| EBITDA(a) | $-10,216 | $-11,560 | $-8,739 | $-10,366 | $-9,157 |